(CIDRAP News) – A five-country study from Europe indicates that the use of adjuvanted vaccines against the pandemic H1N1 influenza virus probably did not increase the risk of Guillain-Barre syndrome (GBS), but the investigators could not firmly rule out a slightly greater chance of suffering the paralytic condition.
(CIDRAP News) In the largest study of its kind so far to assess how well 2009 H1N1 vaccines performed in the pandemic setting, new findings from seven European countries showed they provided good protection, a result that mirrors early clinical studies.
(CIDRAP News) A thorough surveillance study from France reinforces findings from other countries about obesity and delayed antiviral treatment as risk factors for severe 2009 H1N1 influenza, while indicating that the pandemic put a greater burden on intensive care units (ICUs) than seasonal flu typically does.
(CIDRAP News) While donor countries and organizations have responded well to the need for pandemic flu vaccine for developing countries, the level of giving for other pandemic response efforts in needy countries so far has fallen short, the World Health Organization (WHO) said in a recent report.
(CIDRAP News) The head of the World Health Organization (WHO), responding today to recent criticism of WHO policies regarding conflicts of interest and transparency, said the agency needs to tighten its rules for relations with industry but insisted that commercial interests never influenced her decisions regarding the H1N1 influenza pandemic.
(CIDRAP News) An article published by the British Medical Journal says three scientists who helped frame World Health Organization (WHO) guidance on pandemic influenza preparedness had consulted for pharmaceutical companies that stood to profit from the WHO guidance and that the WHO did not disclose the scientists' industry ties.